2015
DOI: 10.14260/jemds/2015/1566
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Pattern of Antimicrobial Resistance of Helicobacter Pylori in Patients of Dyspepsia of Rural Area

Abstract: BACKGROUND:Helicobacter Pylori is a gastric pathogen that chronically infects more than half of the world's population. Unless treated, colonization usually persists lifelong. H. pylori infection represents a key factor in the etiology of various gastrointestinal diseases, ranging from chronic active gastritis without clinical symptoms to peptic ulceration, gastric adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma. Helicobacter pylori eradication rate varies in different parts of the world… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(10 citation statements)
references
References 3 publications
0
10
0
Order By: Relevance
“…Furazolidone was used in H. pylori treatment in India in the studies of Gehlot et al [ 25 ], Pandey et al [ 21 ], and Malhotra et al [ 27 ]. Despite of its infrequent use, the resistance was high (14%).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Furazolidone was used in H. pylori treatment in India in the studies of Gehlot et al [ 25 ], Pandey et al [ 21 ], and Malhotra et al [ 27 ]. Despite of its infrequent use, the resistance was high (14%).…”
Section: Discussionmentioning
confidence: 99%
“… Forest Plot Showing Metronidazole Resistance. (*: the same study with data from two countries, Reference Studies: [ 14 , 15 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 29 , 30 , 31 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ]). …”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…Clarithromycin‐resistant H. pylori (Cla R ) was found in 33.39% (352/1054) samples. The resistance was highest in West India at 58.8% (47/80) followed by South India at 48.7% (208/427), Central India at 19.2% (5/26), and North India at 23.96% (81/338) 24 (Table 2). The resistance rate was 6.3% (11/172) in the Eastern regions and nil in the North‐Eastern regions of India (Figure S2).…”
Section: Resultsmentioning
confidence: 99%
“…Fewer data are available for resistance rates of certain antibiotics which are as follows ciprofloxacin in Gujarat (40/80, 50%), 22 Chhattisgarh (1/26, 3.8%), 24 and Lucknow (3/25, 12%); 23 for amoxicillin and tetracycline. 3 The maximum resistance rate was observed at 48.8% (39/80) for ciprofloxacin and clarithromycin.…”
Section: As Given Inmentioning
confidence: 99%